The Lancet Neurology·24 SepDynamic changes in plasma biomarkers of Alzheimer's disease in patients treated with lecanemab: a longitudinal cohort studyStudy in peopleInterventionsPaper
The Lancet Neurology·9 SepFluid biomarkers in the evolving care landscape of Alzheimer's disease and related disordersReviewBiomarkersPaper